(Q28546682)

English

High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis (English)

0 references

0 references

0 references

extensively drug-resistant tuberculosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Paul van Helden

9

0 references

11

0 references

Elizabeth Streicher

3

0 references

Neesha Rockwood

object named as

Neesha Rockwood

5

0 references

Robin M. Warren

object named as

Robin Warren

10

0 references

author name string

Elize Pietersen

1

0 references

Jonny Peter

2

0 references

Frik Sirgel

4

0 references

Barbara Mastrapa

6

0 references

Julian Te Riele

7

0 references

Malika Davids

8

0 references

language of work or name

0 references

publication date

2015

0 references

0 references

10

0 references

4

0 references

e0123655

0 references

copyright license

Creative Commons Attribution 4.0 International

24 April 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

19 March 2017

Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

19 March 2017

What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

19 March 2017

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

19 March 2017

Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

29 September 2017

Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

29 September 2017

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

29 September 2017

Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

29 September 2017

Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

29 September 2017

Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

29 September 2017

High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

29 September 2017

Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

29 September 2017

Comprehensive treatment of extensively drug-resistant tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

29 September 2017

Pharmacology of the antimycobacterial drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409172

29 September 2017

Totally drug-resistant tuberculosis in India.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0123655

21 January 2018

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0123655

21 January 2018

Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0123655

21 January 2018

Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0123655

21 January 2018

Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0123655

21 January 2018

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25909847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/25909847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0123655

0 references

2015PLoSO..1023655P

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28546682&oldid=1857403750"